Exploring the Mechanism of Action of Modified Lai-Fu Decoction in Chronic Heart Failure Based on Bioinformatics and Network Pharmacology
Year: 2026
Type: article
Abstract: Background The study was principally intended to explore mechanisms and hub drug targets through which modified Lai-Fu decoction (MLFD) acts against chronic heart failure (HF). Methods Using differential gene analysis and network pharmacology, we identified intersecting genes between HF-related genes (HRGs) and targets of active components in MLFD, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Weighted gene coexpression network analysis (WGCNA) was performed to further identify gene modules associated with HF. The final core-gene set was obtained by intersecting these module genes with overlapping genes and lipid metabolism-related genes (LMRGs). Core targets were identified via the protein-protein interaction (PPI) network, Boruta, and Least Absolute Shrinkage and Selection Operator (LASSO). Grounded in seven machine learning algorithms, an ensemble learning model was established to determine hub genes, with their pivotal functions in HF treatment further verified by PPI, KEGG, and molecular docking. Results 46 active ingredients and 289 corresponding targets were identified from MLFD. Intersection analysis of these targets with HRGs yielded 144 HF-associated drug targets. As functional enrichment analysis revealed, target genes were predominantly enriched in insulin resistance signaling pathways and lipid metabolism biological processes. 144 overlapping genes were further intersected with the HF module genes and LMRGs, yielding 15 pivotal targets. Four core target genes were subsequently identified from 15 pivotal targets by employing machine learning. Concurrently, the hub targets exhibit stable binding affinities with kaempferol, isoliquiritigenin, and other active components in MLFD. Conclusions MLFD exerts anti-HF effects by modulating lipid metabolism reprogramming.
Institution: Baicheng Medical College
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,390
OpenAlex ID: W7225897452
